Colleen Redlinger
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Physiology top 10%
Papers in
- Oncology 4
- Pancreatic and Hepatic Oncology Research 2
- Cancer Treatment and Pharmacology 1
-
- Glutathione Transferases and Polymorphisms 1
- Single-cell and spatial transcriptomics 1
- Co-authors
- Mark H. O’Hara (4 shared papers)Peter J. O’Dwyer (6 shared papers)Taylor A. Black (2 shared papers)Erica L. Carpenter (2 shared papers)Neha Bhagwat (2 shared papers)Jina Ko (2 shared papers)Ben Z. Stanger (2 shared papers)Stephanie S. Yee (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (1 paper)ACS Nano (1 paper)Cancer Research (1 paper)Lab on a Chip (1 paper)
- Partner nations
- United States
In The Last Decade
Colleen Redlinger
9 papers receiving 555 citations
Colleen Redlinger's Hit Papers
Peers
Comparison fields: 5 of 71
- Cancer Research 140
- Physiology 33
- Oncology 166
- Molecular Biology 260
- Epidemiology 104
Countries citing papers authored by Colleen Redlinger
This map shows the geographic impact of Colleen Redlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Redlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Redlinger more than expected).
Fields of papers citing papers by Colleen Redlinger
This network shows the impact of papers produced by Colleen Redlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Redlinger. The network helps show where Colleen Redlinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Colleen Redlinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer Hit paper breakdown → | 2019 | 225 |
| 2 | 2017 | 209 | |
| 3 | 2017 | 40 | |
| 4 | 2019 | 36 | |
| 5 | 2009 | 27 | |
| 6 | 2014 | 16 | |
| 7 | 2021 | 3 | |
| 8 | 2012 | 2 | |
| 9 | 2018 | 1 |
About Colleen Redlinger
Colleen Redlinger is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 9 papers that have together received 559 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Advanced Breast Cancer Therapies (2 papers), Glutathione Transferases and Polymorphisms (1 paper), Microfluidic and Bio-sensing Technologies (1 paper), Cancer Treatment and Pharmacology (1 paper), Single-cell and spatial transcriptomics (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (140 citations), Physiology (33 citations), Oncology (166 citations), Molecular Biology (260 citations) and Epidemiology (104 citations). Colleen Redlinger has collaborated with scholars based in United States. Frequent co-authors include Mark H. O’Hara, Peter J. O’Dwyer, Taylor A. Black, Erica L. Carpenter, Neha Bhagwat, Jina Ko, Ben Z. Stanger, Stephanie S. Yee, David Issadore and Arturo Loaiza‐Bonilla. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, ACS Nano, Cancer Research and Lab on a Chip.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.